Akebia Therapeutics, Inc. - AKBA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | CEO and President | M | D | 350,000.0 | 0.0 | 0.0 | 525,000.0 | View | |
| Aug 10, 2026 | CEO and President | M | A | 350,000.0 | 0.63 | 220,500.0 | 3,718,564.0 | View | |
| Jul 01, 2026 | SVP, CFO, CBO & Treasurer | S | D | 56,019.0 | 1.11 | 62,181.09 | 616,616.0 | View | |
| Jun 22, 2026 | — | A | A | 53,600.0 | 0.0 | 0.0 | 53,600.0 | View | |
| Jun 22, 2026 | — | A | A | 35,700.0 | 0.0 | 0.0 | 169,081.0 | View | |
| Jun 22, 2026 | — | A | A | 53,600.0 | 0.0 | 0.0 | 53,600.0 | View | |
| Jun 22, 2026 | — | A | A | 35,700.0 | 0.0 | 0.0 | 196,633.0 | View | |
| Jun 22, 2026 | — | A | A | 53,600.0 | 0.0 | 0.0 | 53,600.0 | View | |
| Jun 22, 2026 | — | A | A | 35,700.0 | 0.0 | 0.0 | 197,429.0 | View | |
| Jun 22, 2026 | — | A | A | 53,600.0 | 0.0 | 0.0 | 53,600.0 | View | |
| Jun 22, 2026 | — | A | A | 35,700.0 | 0.0 | 0.0 | 165,200.0 | View | |
| Jun 22, 2026 | — | A | A | 53,600.0 | 0.0 | 0.0 | 53,600.0 | View | |
| Jun 22, 2026 | — | A | A | 35,700.0 | 0.0 | 0.0 | 145,100.0 | View | |
| Jun 22, 2026 | — | A | A | 53,600.0 | 0.0 | 0.0 | 53,600.0 | View | |
| Jun 22, 2026 | — | A | A | 35,700.0 | 0.0 | 0.0 | 236,200.0 | View | |
| Apr 03, 2026 | — | A | A | 214,400.0 | 0.0 | 0.0 | 214,400.0 | View |